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Abstract
Background: In April 2014 the UK government launched the ‘NHS Visitor and Migrant Cost Recovery Programme
Implementation Plan’ which set out a series of policy changes to recoup costs from ‘chargeable’ (largely non-UK
born) patients. In England, approximately 75% of tuberculosis (TB) cases occur in people born abroad. Delays in TB
treatment increase risk of morbidity, mortality and transmission in the community. We investigated whether
diagnostic delay has increased since the Cost Recovery Programme (CRP) was introduced.
Methods: There were 3342 adult TB cases notified on the London TB Register across Barts Health NHS Trust
between 1st January 2011 and 31st December 2016. Cases with missing relevant information were excluded. The
median time between symptom onset and treatment initiation before and after the CRP was calculated according
to birthplace and compared using the Mann Whitney test. Delayed diagnosis was considered greater or equal to
median time to treatment for all patients (79 days). Univariable logistic regression was used to manually select
exposure variables for inclusion in a multivariable model to test the association between diagnostic delay and the
implementation of the CRP.
Results: We included 2237 TB cases. Among non-UK born patients, median time-to-treatment increased from 69
days to 89 days following introduction of CRP (p < 0.001). Median time-to-treatment also increased for the UK-born
population from 75.5 days to 89.5 days (p = 0.307). The multivariable logistic regression model showed non-UK born
patients were more likely to have a delay in diagnosis after the CRP (adjOR 1.37, 95% CI 1.13–1.66, p value 0.001).
Conclusion: Since the introduction of the CRP there has been a significant delay for TB treatment among non-UK
born patients. Further research exploring the effect of policies restricting access to healthcare for migrants is
urgently needed if we wish to eliminate TB nationally.
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Background
In 2017, 1.6 million people died from world’s deadliest,
yet curable, infectious disease - tuberculosis (TB). TB is
an infectious disease transmitted by coughing. Whilst
some people become unwell straight away, some carry
the infection with no symptoms for many years, this is
termed latent TB infection (LTBI). People living in
countries with a high incidence of TB are at higher risk
of contracting the infection that people living in places
where TB is less common.
TB is unequally distributed; the world’s poorest people
bear a disproportionate burden of disease [1]. In high-
income, low-incidence settings such as the UK, the
majority of active TB cases occur among migrants com-
ing from countries where TB is more common [2].
Countries of origin amongst foreign-born patients reflect
both migrant flows and the global distribution of TB,
with the highest numbers of cases amongst people from
high TB-incidence regions such as South Asia and Sub-
Saharan Africa. In the UK, evidence suggests that TB in
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the migrant population is largely due to reactivation of
latent TB infection, originally acquired abroad [3, 4].
There is no internationally recognised definition of the
term migrant and in other contexts it can be used to
refer to an individual who has moved away from their
usual place of residence to another region within a
country or across international borders to another coun-
try. In this paper the term migrant is used to refer to an
international migrant. With respect to this study this
includes any person living within the UK who was not
originally born there. This definition incorporates many
different categories of migrant including but not limited
to so-called ‘economic migrants’, refugees, asylum-
seekers, failed asylum-seekers and undocumented
migrants.
Strategies to control TB centre around three key prin-
ciples: early diagnosis; effective treatment; and preventa-
tive interventions for those at high risk (including both
treatment of latent TB infection (LTBI) and BCG vaccin-
ation) [5]. The insidious, non-specific nature of symp-
toms associated with TB, such as fevers and weight loss,
often translate into circuitous journeys to diagnosis, in-
volving many different healthcare providers [6, 7]. The
window of time that elapses between symptom onset
and treatment is critical. If the time-to-diagnosis in-
creases, the individual concerned is exposed to higher
risk of morbidity and mortality, and, for infectious cases,
the wider public is exposed to the risk of disease trans-
mission [8–10].
Recent theoretical frameworks to describe healthcare
access account for a complex and dynamic process,
shaped by social interactions within particular contexts.
‘Candidacy’, for example, has frequently been employed
to understand individuals’ experiences of accessing
healthcare and describes “the ways in which people’s
eligibility for medical attention and intervention is
jointly negotiated between individuals and health
services” [11, 12]. Included in this concept is the influ-
ence of “policy imperatives”.
The UK National Health Service (NHS) is a tax-
funded system designed to provide care, free at the point
of delivery. Eligibility for free NHS healthcare is deter-
mined by the test of ‘ordinary residence’; tourists and
some migrants are required to pay for care [13]. Over re-
cent years one policy imperative has been to ensure that
individuals not ordinarily resident in the UK make a ‘fair
contribution’ to the NHS. Changes in the Immigration
Acts 2014 and 2016 have provided the legislative frame-
work which has resulted in tightening of the definition
of ordinary residence – the test of eligibility for free
NHS care - and strengthening of mechanisms for cost
recovery from chargeable individuals. Experiences of
people from the Windrush generation published in
mainstream media between 2017 and 2018 illuminated
the broader impact of these policies: Individuals denied
access to treatment such as chemotherapy because they
could not demonstrate eligibility for free NHS care.
The health service in the UK is devolved; the policies
discussed in this paper are specific to England. The NHS
Visitor and Migrant Cost Recovery Programme (CRP),
introduced in April 2014, was designed to ensure mi-
grants in England who are otherwise ineligible for free
NHS care make a ‘fair contribution’ [14] to the cost of
running the NHS. Policies such as this may play an
important role in shaping patients’ experiences of
healthcare access [11, 12, 15, 16].
The CRP was supported by changes to legislation in-
cluding the Immigration Act 2014 which increased the
recoverable cost of treatment from 100% of tariff to
150% for ineligible residents from outside the European
Economic Area. The ‘roll-out’ incorporated a range of
new activities: strengthening of overseas visitor manager
teams; more targeted strategies for the identification of
ineligible service-users; introduction of punitive sanc-
tions for NHS Trusts who failed to implement CRP
measures robustly; and incentives enabling the recovery
of increased tariffs from patients [17] (Fig. 1). House of
Commons transcripts on this issue at the time [18],
along with supporting policy documents [14] detail the
need for a ‘change in culture’ such that determinations
of eligibility and charging should become business-as-
usual within the NHS.
Barts Health NHS Trust serves three East London bor-
oughs and treats over 500 patients with a diagnosis of
active TB each year. This represents approximately 10%
of cases in England. National data is collected on all TB
cases and includes: time between symptom onset and
start of treatment; country of birth; and year of entry to
the UK. Beyond these, migrant subgroups are not further
classified and, in particular, immigration status and eligi-
bility for free NHS care are not recorded. This study
uses routinely collected surveillance data to examine
time to treatment onset among UK-born and non-UK
born populations in this region, before and after imple-
mentation of the CRP.
Methods
The London TB Register (LTBR) is an online database
for the statutory recording of notified cases of TB, as en-
tered by clinical staff. The database contains details of
patient ethnicity; gender; age; place of birth; length of
time resident in the UK; date of symptom onset; date TB
treatment started; occupation; and other medical history.
We collected patient data from the LTBR for TB cases
notified across Barts Health NHS Trust between 2011
and 2016 inclusive. We included all adult cases (≥18
years old) that did not have any missing relevant data.
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We manually reviewed the dataset and categorised pa-
tients for the analysis as follows. Time in the UK was
categorised as 0–1 years, 2–5 years, 6–10 years, or 11+
years. Patient occupation was classified using Office of
National Statistics guidance as “managerial”, “intermedi-
ate”, “unskilled”, “unemployed”, “housewife/ house
husband”, “student”, “unknown”, or “retired” [19]. We
identified patients as having either “no social risk fac-
tors” or “at least one social risk factor” based on the
additional information on the LTBR. Social risk factors
are relevant to adherence rather than risk of infection,
although there is clearly some overlap, and included: his-
tory of incarceration; drug or alcohol dependence;
homelessness; and mental health concerns.
We identified patients as either “pre-CRP” or “post-
CRP” according to the date they started their treatment
for TB (before or after 1st April 2014, respectively).
April 1st 2014 was the date provided in the policy. It
signifies a conservative estimate of the beginning of the
implementation of a complex series of policies and prac-
tices designed to restrict healthcare access for some
groups of people not born in the UK. We also cate-
gorised patients as either “UK-born” or “not UK-born”
based on place of birth data in the LTBR. In 59 cases,
there was no data on treatment start date recorded in
the LTBR database. For these cases we used the date the
patient was first seen in TB clinic as a proxy measure.
Statistical analysis
All data handling and statistical analyses were performed
using Stata version 15 (StataCorp, Texas). Statistical
significance was set at 5% for all tests. The median time
to treatment was selected as the outcome of interest due
to a combination of robustness against outliers, a lack of
normal distribution in the time to treatment data, and
simplicity of understanding. The Chi square test was
used to compare the proportion of patients UK-born or
not UK-born with each baseline characteristic when
grouped as pre-CRP and post-CRP.
The time-to-treatment was calculated for all patients
as the number of days between the date of symptom
onset and the date of starting treatment. The Mann-
Whitney test was used to compare the median time to
treatment for all patients before and after the CRP. The
difference in time to treatment before and after the CRP
was then compared for patients according to their status
as ‘UK-born’ or ‘born outside the UK’, again using the
Mann-Whitney test.
We defined ‘delayed diagnosis’ as any patient with a
time to treatment greater than the median value for all
patients. We defined delay in this way because there is
no established definition of what constitutes a delayed
diagnosis of TB available in the literature [8]. In addition
healthcare access is highly contextual and so applying al-
ternative conceptions of delay from other regions or
countries would not be appropriate. The proportion of
all patients with a ‘delayed diagnosis’ before and after
the CRP was investigated using the Chi square test,
followed by patients according to their UK-born status.
Assumptions relating to the Chi-square test, including
minimum number for expected value per cell, were
found to have been met.
Logistic regression was used to investigate the rela-
tionship between diagnostic delay (as a binary outcome)
and whether date of diagnosis was before or after the
CRP for patients born outside the UK. Variables were
manually selected based on significance level in a uni-
variable model (p value < 0.10) with the exposure (treat-
ment before or after the CRP) and outcome variables
(delay in diagnosis). These were included, along with sex
Fig. 1 Phased approach reproduced from the Visitor & Migrant Cost Recovery Programme Implementation Plan 2014–2016
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and age, in a final multivariable logistic regression model
testing the association between delay in diagnosis and
introduction of the CRP to account for potential con-
founding. The regression model was tested using the
Hosmer-Lemeshow test, and the minimum number of
measurements was thought to have been reached in each
of the two patient groups based on the number of vari-
ables being tested.
Results
A total of 3342 cases were added to the LTBR between
January 2011 and December 2016. There were 2237
cases were included in the final analysis (see Table 1).
The median time to treatment for all included patients
was 79 days. In the time period prior to the introduction
of the CRP the median time to treatment was 70 days
for all patients and this increased to 89 days after the
CRP was introduced (p value< 0.001).
Of note, significantly more UK-born patients had more
than one social risk factor compared with non-UK born
patients (Chi-squared p < 0.001). There was also a sig-
nificant increase in the number of years migrant patients
had been living in the UK before their diagnosis with TB
pre-CRP (10 years) and post-CRP (14.8 years, Chi-
squared p value p < 0.001).
There was a significant increase in the time-to-
treatment for non-UK born patients following the imple-
mentation of the CRP (see Table 2 and Fig. 2). Pre-CRP,
the median time to treatment was 69 days in this group,
increasing to 89 days post-CRP (p value < 0.0001). There
was also an increase in the median time to treatment for
UK-born patients post-CRP (75.5 days vs 89.5 days) but
this increase was not significant (p = 0.307). The propor-
tion of patients categorised as having a delayed diagnosis
according to place of birth and CRP timing are shown in
Table 3.
After univariable analysis the following variables had
associated p values < 0.10 and were included as exposure
variables to adjust for confounding in the final multivari-
able logistic regression model due to a p value > 0.10:
patient age; gender; time in the UK (as a categorical vari-
able); and the presence of one or more social risk factors
for TB. We excluded the following variables from the
model: being born in an English-speaking country, site
of TB disease, previous TB and being a healthcare
worker because no association was found on univariate
analysis.
Table 4 shows the results from the multivariable logis-
tic regression analysis for patients born outside the UK.
There was a significant association with treatment delay
from the onset of symptoms in a multivariable logistic
regression model (adjusted OR 1.37, 95% CI 1.13–1.66,
p value < 0.01) among this group. Increasing age was
also positively associated with treatment delay for pa-
tients born outside the UK. Conversely, the presence of
one or more social risk factors was negatively associated
with a treatment delay. The Hosmer-Lemeshow
goodness-of-fit test was not statistically significant (p =
0.4596) suggesting the model is consistent and adequate
to explain the observed outcome.
Discussion
In 2016 the average time between symptom onset and
starting treatment for pulmonary TB in England was 77
Table 1 Baseline characteristics for patients diagnosed before and after CRP based on UK-born status
Pre-CRP Post-CRP
UK born Non-UK born UK born Non-UK born
Total cases 166 1037 170 864
Median age (IQR) 32.0 (23–46) 32.0 (26–45) 33.5 (25–47) 37.0 (29–49)
Sex
Female (%) 43.5 36.9 32.5 37.5
Male (%) 56.5 63.1 77.5 62.5
Pulmonary TB Cases (% Smear Positive) 109 (45.87) 428 (36.5) 101 (31.7) 367 (33.9)
Extra-pulmonary TB cases (% of total cases) 61 (35.6) 609 (58.7) 65 (39.2) 497 (57.5)
% with ≥1 social risk factors 20.0 6.5 18.7 7.6
Table 2 Median time to diagnosis before/after the CRP for all
patients, and then stratified by UK-born status
Patient group Median time to diagnosis (days) p value
All
Before-CRP 70 0.001
After-CRP 89
UK-born
Before-CRP 75.5 0.307
After-CRP 89.5
Non-UK Born
Before-CRP 69 < 0.001
After-CRP 89
CRP Cost Recovery Program
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days [2]. A key aim of Public Health England and NHS
England’s Collaborative Tuberculosis Strategy is to “im-
prove access to services and ensure early diagnosis” [20].
This study has identified that, since the implementation
of the CRP, migrants in East London are more likely to
experience delay in treatment of their TB. This is an im-
portant finding since the longer the delay in diagnosing
TB, the greater the morbidity [21] and mortality [22] for
the individual, and the greater the risk of transmission in
the community [23].
There are a number of potential mechanisms at play
which may be relevant in the association between the
experiences of migrants accessing healthcare and health
policies that restrict access to care based on immigration
status [11, 12]. There is already evidence to show that
migrants in the UK are often not aware of their entitle-
ments to care [24]. This is further complicated by recent
legislative changes that have altered who is eligible for
care and who is not, including the introduction of an
immigration health surcharge that accompanies visa ap-
plications [25]. Previous research has shown patients’
concerns about being charged for care delay health-
seeking, even before a diagnosis has been made [26–28].
This is important because diagnosis and treatment of
TB, like many other infectious diseases, is exempt from
charging in the UK, regardless of immigration status
[29]. Crucially, however, patients present with undiffer-
entiated symptoms - not a diagnosis - and many may be
unaware of the details of the regulations [30].
Recent evidence suggests the CRP is just one policy
among several which constitute a broader ‘hostile envir-
onment’ aimed at people living in the UK illegally [31].
For example a data-sharing agreement between NHS
Digital and the Home Office [32, 33] requires that NHS
staff report people with an outstanding bill exceeding
£500 to the Home Office. Significant sharing of patients’
demographic information between the NHS and the
Home Office has been reported [34].
The ‘hostile environment’ is an important socio-
political context within which people make decisions
about seeking help, including decisions regarding
whether and how they identify themselves as a candidate
for health care [35]. This effect may be independent of
their legal eligibility for free care. Fear as a deterrent to
healthcare access among migrants has been well docu-
mented in several countries including the UK [24, 36].
In 2012 the government made clear their explicit
intention to create a “really hostile environment” for
those living in the UK without the legal right to do so
Fig. 2 Boxplot showing time to diagnosis (in days) by a) whether
patients were treated before or after the introduction of the Cost
Recovery Program (CRP), sub-catergorised by place of birth and by
b) place of birth, before and after the introduction of the CRP. Times
to diagnosis above 350 days have not been displayed. Time to
diagnosis: days from onset of symptoms to starting treatment
Table 3 Proportions of UK-born and Non-UK born patients with a recorded delay in diagnosis before and after the introduction of
the CRP. Delay in diagnosis is greater than or equal to median time (79 days) for all patients. Row percentages shown for
proportions of patients with diagnostic delay
Place of birth Delay in Diagnosis Delay (Row %) No Delay (Row %) P value
UK-Born Pre-CRP 82 (48.2) 88 (51.8) 0.227
Post-CRP 91 (54.8) 75 (45.2)
Non-UK Born Pre-CRP 462 (44.6) 575 (55.5) < 0.001
Post-CRP 477 (55.2) 387 (44.8)
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[37]. Aside from the CRP, other measures included: a
rise in immigration raids; the prospect of unlimited de-
tention; the threat to health and even life that immigra-
tion detention poses [38, 39]; school meals withheld
because of parents’ immigration status [40], restrictions
to the housing rental market, driving licenses and bank
accounts in similar ways to the restrictions applied to
the NHS [41]. The influence of these other ‘hostile en-
vironment’ policies have not been accounted for within
this study but may have contributed to the overall
findings.
There are other contemporaneous policy-related con-
texts which may be relevant to the increase in time to
treatment reported in this study. Access to translation
services have changed due to imposed cuts under condi-
tions of austerity. Across the NHS, staffing levels de-
creased and waiting times for hospital care increased
during the study period amidst concerns of an NHS ‘in
crisis’ [42]. It is important to consider whether local
changes in service provision may have impacted the re-
sults. The study data is collected from three London
boroughs each served by a hospital with an A&E and
local respiratory and TB services. Whilst there was an
increased focus on TB among migrants during the study
period, including education and awareness raising in pri-
mary care and local communities, no other major service
changes occurred during this time. Finally, as with all
observational analyses, causal associations cannot be in-
ferred between the implementation of the CRP and the
significant increase in the time to diagnosis.
Our study shows the UK-born population experienced
a non-significant increase in the time to treatment of
TB. A significantly higher proportion of UK-born pa-
tients had one or more social risk factors compared with
those not born in the UK. This is reflective of national
data [2]. Therefore the UK-born population is potentially
more vulnerable to the effects of austerity; health suffers
whilst individuals manage other competing priorities
such as employment, housing, and limited income
(earned or through welfare) restricting their means to
access care [43]. This would result in an underestimation
of effect. Conversely, clinicians’ sensitivity to TB as a dif-
ferential diagnosis is likely to be heightened among pa-
tients with particular risk factors such as homelessness.
However, not being born in the UK – particularly indi-
viduals from high TB incidence countries – is also likely
to increase alertness amongst clinicians to the possibility
of a TB diagnosis.
Nevertheless, these factors do not explain why only
the non-UK born population experienced a significant
delay in time to diagnosis and treatment following the
introduction of the CRP whilst the UK-born population
did not. Of note, migrants diagnosed with TB after 2014
had been in the UK significantly longer than those diag-
nosed before. There may be a number of reasons for this
such as changes to immigration policies and the intro-
duction of pre-entry TB screening [44]. Nonetheless,
‘newness’ of migrants has been associated with increased
difficulty accessing care [35, 45] potentially resulting in
an under estimation of the effect size.
Whilst the study area is geographically small, it ac-
counts for approximately 10% of all cases of TB in the
UK during the research period [2]. TB in the UK is
largely focused in urban areas with large migrant com-
munities. Thus it is possible our findings may be applic-
able to other areas within England which have similar
migrant populations and have been subject to similar
policies designed to restrict access to healthcare for
some migrants and visitors. However, this study does
not demonstrate causality and further research is re-
quired to examine the nature of the relationship between
different categories of migrant, their eligibility for free
NHS care and the complex and evolving arena of laws,
policies and practices which shape access to TB
treatment.
There are a number of limitations to the study. This
paper does not claim causality but nevertheless
Table 4 Results of the multivariable logistic regression model
with exposure variables shown as rows. Odds ratios relate to
the binary outcome variable of diagnostic delay (greater than or
equal to median time to diagnosis). Results shown are only for
patients born outside the UK. Social risk factors for TB included
history of alcohol dependence, recreational drug use,
homelessness or imprisonment
Adjusted Odds Ratio
(95% confidence interval)
p value
Treatment after CRP 1.37 (1.13–1.66) 0.001
Age 1.01 (1.00–1.02) 0.010
Sex 1.13 (0.92–1.40) 0.245
Time in the UK
0–1 year REFERENCE n/a
2–5 years 1.05 (0.77–1.43) 0.779
6–10 years 0.96 (0.68–1.36) 0.834
11+ years 1.14 (0.81–1.59) 0.452
Occupation
managerial/professional REFERENCE n/a
Intermediate 0.86 (0.54–1.35) 0.512
Unskilled 0.82 (0.52–1.30) 0.405
Unemployed 0.73 (0.46–1.16) 0.182
Housewife/Househusband 0.74 (0.44–1.24) 0.253
Student 0.62 (0.38–1.02) 0.061
Unknown 0.59 (0.32–1.09) 0.089
Retired 0.43 (0.23–0.78) 0.006
1 or more social risk factor for TB 0.76 (0.61–0.96) 0.019
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demonstrates an important association that warrants
further investigation. The ability to communicate in the
language of the host country has been shown to affect
healthcare access as well as the quality of care received
by migrants [46], however English language ability is not
routinely collected. Immigration status has also been
shown to affect healthcare access [47] but is not rou-
tinely collected. It was therefore not possible to differen-
tiate between migrants eligible for free NHS care and
those who are not. Socio-economic status was deter-
mined through a proxy measure – occupational status –
which has well-documented limitations [48]. A binary
cut-off before and after the CRP does not reflect the
reality of a policy which was rolled out over subsequent
years. The unbalanced nature of the numbers in the UK-
born and non-UK-born groups should not have intro-
duced bias to the tests for significance used here but
could have had an impact on the power of these tests to
detect significant differences. One potential way to try to
address this asymmetry in future work could be to em-
ploy matching, however careful thought would have to
go into the selection of matching criteria. There are
other techniques that could have been used to analyse
the data that would account for the longitudinal nature
the dataset, such as an interrupted time series analysis.
However, this would introduce additional assumptions
such as linearity of the data, predictable change in time-
varying external factors, and autocorrelation. The find-
ings presented here merely suggest an association with
time as a binary variable using a simple test of
proportion.
Conclusion
This research demonstrates a significant association be-
tween diagnostic delay for patients with TB who were
not born in the UK and policies which restrict health-
care access to visitors and migrants not entitled to free
NHS care. Whilst there is little evidence of TB transmis-
sion outside of migrant communities [49], it remains the
case that policies which limit access to healthcare for
particular populations have significant implications not
only for the health of these individuals but that of the
general public. In the case of TB in England, and applic-
able to other low TB-burden countries where the major-
ity of cases occur among migrants, restricting healthcare
access for this population undermines national efforts to
eliminate TB. Finally, as the recent UCL-Lancet commis-
sion on migration and health highlights, governments
have a “moral and legal obligation” to uphold the right
to the highest attainable standard of health for all
people, no matter their immigration status [16].
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